Michael R Mcdonnell - Net Worth and Insider Trading

Michael R Mcdonnell Net Worth

The estimated net worth of Michael R Mcdonnell is at least $3 Million dollars as of 2023-03-31. Michael R Mcdonnell is the EVP and CFO of IQVIA Holdings Inc and owns about 14,366 shares of IQVIA Holdings Inc (IQV) stock worth over $3 Million. Michael R Mcdonnell is also the Former EVP, CFO of DISH Network Corp and owns about 720 shares of DISH Network Corp (DISH) stock worth over $6,487. Details can be seen in Michael R Mcdonnell's Latest Holdings Summary section.

Transaction Summary of Michael R Mcdonnell

To

Michael R Mcdonnell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael R Mcdonnell owns 7 companies in total, including Biogen Inc (BIIB) , IQVIA Holdings Inc (IQV) , and Frontier Communications Corp (FTRPR.PFD) among others .

Click here to see the complete history of Michael R Mcdonnell’s form 4 insider trades.

Insider Ownership Summary of Michael R Mcdonnell

Ticker Comapny Transaction Date Type of Owner
BIIB Biogen Inc 2020-08-15 EVP & Chief Financial Officer
IQV IQVIA Holdings Inc 2015-12-16 Chief Financial Officer
FTRPR.PFD Frontier Communications Corp 2019-04-01 director
IMS IMS Health Holdings Inc 2017-07-05 EVP and CFO
DISH DISH Network Corp 2004-06-30 EVP & Chief Financial Officer
FYBR Frontier Communications Parent Inc 2018-12-12 director
MMSI Merit Medical Systems Inc 2022-05-19 director

Michael R Mcdonnell Latest Holdings Summary

Michael R Mcdonnell currently owns a total of 2 stocks. Among these stocks, Michael R Mcdonnell owns 14,366 shares of IQVIA Holdings Inc (IQV) as of January 2, 2020, with a value of $3 Million and a weighting of 99.77%. Michael R Mcdonnell also owns 720 shares of DISH Network Corp (DISH) as of September 7, 2004, with a value of $6,487 and a weighting of 0.23%.

Latest Holdings of Michael R Mcdonnell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IQV IQVIA Holdings Inc 2020-01-02 14,366 194.95 2,800,652
DISH DISH Network Corp 2004-09-07 720 9.01 6,487

Holding Weightings of Michael R Mcdonnell


Michael R Mcdonnell Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael R Mcdonnell has made a total of 2 transactions in IQVIA Holdings Inc (IQV) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in IQVIA Holdings Inc is the sale of 12,000 shares on January 2, 2020, which brought Michael R Mcdonnell around $2 Million.

According to the SEC Form 4 filings, Michael R Mcdonnell has made a total of 0 transactions in DISH Network Corp (DISH) over the past 5 years. The most-recent trade in DISH Network Corp is the sale of 12,000 shares on September 7, 2004, which brought Michael R Mcdonnell around $371,880.

Insider Trading History of Michael R Mcdonnell

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
IQV
IQVIA Holdings Inc
2020-01-02
Sell
12,000.00
-45.51%
$155.07
$1,860,840.00
14,366.00
$194.95
25.72%
-
IQV
IQVIA Holdings Inc
2018-12-03
Sell
9,500.00
-24.81%
$128.35
$1,219,320.00
28,785.00
$194.95
51.89%
-
DISH
DISH Network Corp
2004-09-07
Sell
12,000.00
-94.34%
$30.99
$371,880.00
720.00
$9.01
-70.93%
-
Total 3
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael R Mcdonnell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael R Mcdonnell Ownership Network

Ownership Network List of Michael R Mcdonnell

No Data

Ownership Network Relation of Michael R Mcdonnell


Michael R Mcdonnell Owned Company Details

What does Biogen Inc do?

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.

Who are the key executives at Biogen Inc?

Michael R Mcdonnell is the EVP & Chief Financial Officer of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .

Biogen Inc (BIIB) Insider Trades Summary

Over the past 18 months, Michael R Mcdonnell made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .

In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.

Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biogen Inc Insider Transactions

20/Page
Total 0
Ticker
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Michael R Mcdonnell Mailing Address

Above is the net worth, insider trading, and ownership report for Michael R Mcdonnell. You might contact Michael R Mcdonnell via mailing address: C/o Iqvia Holdings Inc., 83 Wooster Heights Road, Danbury Ct 06810.